Biomark Diagnostics Inc. (FRA:20B)
Germany · Delayed Price · Currency is EUR 0.3080
0.00 (0.00%)
At close: Jul 7, 2026
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of €32.8 million as of July 7, 2026. Its market cap has increased by 67.79% in one year.
Market Cap
32.80M
Enterprise Value
32.44M
Revenue
57.01K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.31
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has increased from 28.50M to 32.80M, an increase of 15.09%. That is a compound annual growth rate of 1.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 32.80M | 0.67% |
| Dec 30, 2025 | 32.58M | 228.85% |
| Dec 30, 2024 | 9.91M | -19.08% |
| Dec 29, 2023 | 12.24M | 23.53% |
| Dec 30, 2022 | 9.91M | -23.89% |
| Dec 30, 2021 | 13.02M | 134.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 80.40M |
| 2invest AG | 45.29M |
| Vidac Pharma Holding | 25.24M |
| Paion AG | 392.35K |
| co.don AG | 374.13K |
| bioXXmed AG | 213.41K |
| MagForce AG | 91.72K |